Abstract

Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.


Claims
Owners (US)
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 12, 2016
  • Application: Mar 13, 2014
    US US 201414209927 A
  • Priority: Mar 13, 2014
    US US 201414209927 A
  • Priority: Jan 15, 2014
    US US 201461927717 P
  • Priority: Dec 20, 2013
    US US 201361919208 P
  • Priority: Jul 8, 2013
    US US 201361843540 P

Sign in to the Lens